Michael is a highly experienced senior corporate finance and strategic advisory professional focused on the healthcare sector. Michael has demonstrated proven leadership and a track record of successful transaction origination and execution at Wall Street bulge bracket and middle-market investment banking firms. Throughout his 20+ year investment banking career, Michael has successfully been mandated and/or closed over 65 transactions for private as well as large and small/mid-cap public companies representing over $17 billion in aggregate transaction value.Michael has significant experience leading/managing a wide range of public and private financing transactions including IPOs, follow-on equity offerings, PIPEs, private placements, high yield, high grade, and convertible debt offerings, as well as M&A/financial advisory across a wide variety of sectors in the medical device and life sciences industries.Specialties/Capabilities: Corporate finance/CFO, mergers and acquisitions, strategic advisory, business strategy, financial analysis, financial modelling and valuation